PRPO (Precipio) Current Deferred Revenue: $0.12 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PRPO Precipio Inc PRPO
53 GF Score
Price $22.35
GF Value $10.74
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Precipio Current Deferred Revenue?

Precipio PRPO -1.11% 53 Current Deferred Revenue is $0.12 Mil as of Mar. 2026. GuruFocus rates PRPO with a GF Score™ of 53/100 and a GF Value™ of $10.74 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Precipio's current deferred revenue for the quarter that ended in Mar. 2026 was $0.12 Mil.

Precipio Current Deferred Revenue Related Terms

Precipio Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Precipio's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precipio Current Deferred Revenue Chart

Precipio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.12 0.11 0.23 0.28

Precipio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.28 0.28 0.28 0.12
PRPO
53GF Score
Precipio Inc PRPO
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $0.12 Mil mean?
Precipio (PRPO) has a Current Deferred Revenue of $0.12 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Precipio and its competitors.
Is Precipio's Current Deferred Revenue too high?
Precipio's current Current Deferred Revenue is $0.12 Mil. Overall, Precipio has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Precipio's Current Deferred Revenue compare to IDXG and ADVB?
Precipio's Current Deferred Revenue of $0.12 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Diagnostics & Research company?
A good Current Deferred Revenue depends on the Medical Diagnostics & Research industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Precipio and its competitors. Precipio's current Current Deferred Revenue is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precipio stock overvalued right now?
Based on GuruFocus' analysis, Precipio (PRPO) is currently considered Significantly Overvalued. The stock's GF Value™ is $10.74, compared to a current price of $22.35 — trading 108.1% above its estimated fair value. The current Current Deferred Revenue is $0.12 Mil. Precipio's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Precipio (PRPO), the current Current Deferred Revenue is $0.12 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precipio (PRPO) Overvalued in 2026?

Based on GuruFocus' analysis, Precipio stock appears to be overvalued. The current stock price of $22.35 is trading 108.1% above its estimated GF Value™ of $10.74. GuruFocus considers Precipio to be Significantly Overvalued.

Key valuation signals for PRPO:

  • Current Deferred Revenue: $0.12 Mil
  • GF Value™: $10.74 vs. price of $22.35 (108.1% above fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the PRPO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precipio Business Description

Address 4 Science Park, 3rd Floor, New Haven, CT, USA, 06511
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
53GF Score

Get the complete analysis for PRPO

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.35
Price
$10.74
GF Value